MX2023006696A - Composiciones farmaceuticas que comprenden un agonista cannabinoide. - Google Patents
Composiciones farmaceuticas que comprenden un agonista cannabinoide.Info
- Publication number
- MX2023006696A MX2023006696A MX2023006696A MX2023006696A MX2023006696A MX 2023006696 A MX2023006696 A MX 2023006696A MX 2023006696 A MX2023006696 A MX 2023006696A MX 2023006696 A MX2023006696 A MX 2023006696A MX 2023006696 A MX2023006696 A MX 2023006696A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- cannabinoid agonist
- treatment
- pharmaceutical formulations
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 239000000556 agonist Substances 0.000 title abstract 2
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 abstract 1
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 abstract 1
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 abstract 1
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
Abstract
La presente divulgación se refiere a composiciones farmacéuticas que comprenden el Compuesto I, o una sal farmacéuticamente aceptable de este, como la sustancia activa. Las composiciones farmacéuticas son adecuadas para el uso en formulaciones farmacéuticas de liberación inmediata. Las formulaciones farmacéuticas son adecuadas para el uso en el tratamiento de afecciones médicas en las que el tratamiento con agonistas de los receptores CB1/CB2 es beneficioso.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2019335.5A GB202019335D0 (en) | 2020-12-09 | 2020-12-09 | Pharmaceutical compositions |
PCT/GB2021/053200 WO2022123233A1 (en) | 2020-12-08 | 2021-12-07 | Pharmaceutical compositions comprising cannabinoid agonist |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2023006696A true MX2023006696A (es) | 2023-06-20 |
Family
ID=74165926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2023006696A MX2023006696A (es) | 2020-12-09 | 2021-12-07 | Composiciones farmaceuticas que comprenden un agonista cannabinoide. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20240024290A1 (es) |
EP (1) | EP4259111A1 (es) |
JP (1) | JP2023552495A (es) |
KR (1) | KR20230118122A (es) |
CN (1) | CN116528842A (es) |
AU (1) | AU2021396585A1 (es) |
CA (1) | CA3198758A1 (es) |
GB (1) | GB202019335D0 (es) |
IL (1) | IL303241A (es) |
MX (1) | MX2023006696A (es) |
TW (1) | TW202237091A (es) |
WO (1) | WO2022123233A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1797077B1 (en) | 2004-09-24 | 2012-02-15 | AstraZeneca AB | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i |
TW200745049A (en) * | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
-
2020
- 2020-12-09 GB GBGB2019335.5A patent/GB202019335D0/en not_active Ceased
-
2021
- 2021-07-12 US US18/256,198 patent/US20240024290A1/en active Pending
- 2021-12-07 KR KR1020237022013A patent/KR20230118122A/ko unknown
- 2021-12-07 AU AU2021396585A patent/AU2021396585A1/en active Pending
- 2021-12-07 TW TW110145641A patent/TW202237091A/zh unknown
- 2021-12-07 CA CA3198758A patent/CA3198758A1/en active Pending
- 2021-12-07 MX MX2023006696A patent/MX2023006696A/es unknown
- 2021-12-07 EP EP21827629.3A patent/EP4259111A1/en active Pending
- 2021-12-07 IL IL303241A patent/IL303241A/en unknown
- 2021-12-07 CN CN202180082293.0A patent/CN116528842A/zh active Pending
- 2021-12-07 JP JP2023557835A patent/JP2023552495A/ja active Pending
- 2021-12-07 WO PCT/GB2021/053200 patent/WO2022123233A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2023552495A (ja) | 2023-12-15 |
GB202019335D0 (en) | 2021-01-20 |
WO2022123233A1 (en) | 2022-06-16 |
AU2021396585A1 (en) | 2023-06-22 |
CA3198758A1 (en) | 2022-06-16 |
KR20230118122A (ko) | 2023-08-10 |
IL303241A (en) | 2023-07-01 |
CN116528842A (zh) | 2023-08-01 |
EP4259111A1 (en) | 2023-10-18 |
TW202237091A (zh) | 2022-10-01 |
US20240024290A1 (en) | 2024-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX361590B (es) | Suministro topico de composiciones para la piel que tienen ph bajo. | |
UA99132C2 (ru) | Производные дикарбоновых кислот как агонисты рецепторов s1p1 | |
TW200637874A (en) | Peptides with neuropeptide-2 receptor (Y2R) agonist activity | |
DOP2010000166A (es) | Derivados de aminobenzamida como agentes utiles para el control de parasitos de animales | |
PH12018501236A1 (en) | Pharmaceutical composition comprising a potent inhibitor urat1 | |
TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
IL196289A0 (en) | Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group | |
MX2011008910A (es) | Derivados de azol sustituidos, composicion farmaceutica que comprende los derivados, y uso de los derivados para tratar enfermeda de parkinson. | |
MX2020005942A (es) | Delgada pelicula oral con alta carga de agente activo. | |
MX2021010046A (es) | Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas. | |
SA520411787B1 (ar) | مشتقات بنزيميدازول واستخداماتها | |
PH12014502331B1 (en) | Orally available pharmaceutical formulation suitable for improved management of movement disorders | |
MA38679A1 (fr) | Modulateurs du récepteur de cxcr7 | |
CL2009001267A1 (es) | Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis. | |
EP4234021A3 (en) | Pharmaceutical composition comprising an adenosine derivative for use in the prevention or treatment of diabetic nephropathy | |
MY162554A (en) | Novel benzamide derivatives | |
MX2008010879A (es) | Composiciones farmaceuticas de sodio de fluvastatina. | |
MX2013002649A (es) | Agente terapeutico contra el dolor. | |
MY148732A (en) | Triazolium salts as par1 inhibitors, production thereof, and use as medicaments | |
MX2022004215A (es) | Derivados de 2-azaespiro[3.4]octano como agonistas de m4. | |
MX2023006696A (es) | Composiciones farmaceuticas que comprenden un agonista cannabinoide. | |
AR071585A1 (es) | 4- metil-4,5-dihidro-1h-pirazol-3-carboxamida util como antagonista de cannabinoide cb1 | |
MX2009008176A (es) | Derivados de tetrahidro-naftaleno sustituidos con heterociclos, su preparacion y su uso como medicamentos. | |
MX2013005873A (es) | Formulaciones monoterapeuticas de agonistas beta selectivo, lipofilo y de accion prolongada y procedimientos para el tratamiento cosmetico de adiposidad y abultamiento del contorno. | |
MX2022013890A (es) | Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos. |